Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 3Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Lymphoma 16Leukemia 14Breast Neoplasms 8Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Acute 6Neoplasms, Plasma Cell 5Multiple Myeloma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Burkitt Lymphoma 5Neuroblastoma 4Myelodysplastic Syndromes 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myelomonocytic, Acute 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Hodgkin Disease 4Congenital Abnormalities 4Recurrence 3Myeloproliferative Disorders 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Large-Cell, Anaplastic 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3

Interventions

Paclitaxel 16Carboplatin 15Bevacizumab 7Hyperthermic Intraperitoneal Chemotherapy 5Cisplatin 4Taxes 3Gemcitabine 3Cytoreduction Surgical Procedures 3Chemotherapy, Adjuvant 3oregovomab 2niraparib 2fluzoparib 2Topotecan 2ST 1481 2Neoadjuvant Therapy 2Methods 2Immunohistochemistry 2Ifosfamide 2Gene Expression Profiling 2Filgrastim 2Educational Status 2Early Intervention, Educational 2Amplified Fragment Length Polymorphism Analysis 2rucaparib 1pembrolizumab 1paclitaxel poliglumex 1olaparib 1navicixizumab 1mirvetuximab soravtansine 1liposomal doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Fallopian Tube Neoplasms × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00003064 2014-01-06

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
30 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡